Startups
Be Biopharma
https://be.bioBe Biopharma is developing a proprietary class of engineered B cells as medicines in applications beyond cytotoxicity.
Summary
Total Funding
$264M
- Unknown (2024-10-22) $82.0M
- Series B (2022-04-16) $130M
- Series A (2020-10-26) $52.0M
Investors
- RA Capital Management Unknown
- RA Capital Management Unknown
- Bristol-Myers Squibb Unknown
- Atlas Venture Unknown
- ARCH Venture Partners Unknown
- Longwood Fund Unknown
- Takeda Ventures Unknown
- ARCH Venture Partners Series B
- Bristol-Myers Squibb Series B
- Atlas Venture Series B
- RA Capital Management Series B
- RA Capital Management Series B
- Alta Partners Series B
- Longwood Fund Series B
- Takeda Ventures Series B
- Alta Partners Series A
- Atlas Venture Series A
- Longwood Fund Series A
- Takeda Ventures Series A
- RA Capital Management Series A
- RA Capital Management Series A
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable